Comparison of robot-assisted partial nephrectomy with KangDuo surgical system *** da Vinci Si system:Quality of life and medium-term oncological outcomes

作     者：Zhihua Li Yiwei Huang Xiang Wang Meng Zhang Shubo Fan Fan Liu Shengwei Xiong Kunlin Yang Hua Guan Xuesong Li Liqun Zhou Zhihua Li;Yiwei Huang;Xiang Wang;Meng Zhang;Shubo Fan;Fan Liu;Shengwei Xiong;Kunlin Yang;Hua Guan;Xuesong Li;Liqun Zhou

作者机构：Department of UrologyPeking University First HospitalInstitute of UrologyPeking UniversityNational Urological Cancer CentreBeijing 100034China Department of NursingPeking University First HospitalPeking UniversityBeijing 100034China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志(英文版))

年 卷 期：2024年第137卷第22期

页      面：2767-2769页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：surgical robot annually 

摘      要：To the Editor:Renal cell carcinoma is the most common cancer of the genitourinary tract and leads to over 170,000 deaths annually *** localized tumors,robot-assisted partial nephrectomy(RAPN)has emerged as a popular option due to its numerous benefits,including better ergonomics,better functional outcomes,similar oncological outcomes,and minimal *** KangDuo surgical robot(KD-SR),a novel robotic surgical platform,was developed by SuZhou KangDuo Robot Co.,Ltd.(Suzhou,China).Recently,we reported that the KD-SR achieved noninferior outcomes compared to the da Vinci Si Surgical System(DV-SS-Si)in terms of surgical success for T1a tumors.[1]However,the oncological outcomes of the KD-SR and the DV-SS-Si are yet to be *** this prospective randomized cohort trial,we aimed to compare the patient-reported health-related quality of life(HRQoL)and medium-term oncological outcomes of the KD-SR *** DV-SS-Si for RAPN.